News from aratana therapeutics A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

09:03 ET

Aratana Therapeutics to Participate in Two Upcoming Investor Conferences

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...

May 15, 2015, 08:30 ET

Aratana Therapeutics to Participate in Two Upcoming Investor Conferences

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...

May 14, 2015, 15:30 ET

Aratana Therapeutics to Showcase Extensive Clinical Development Pipeline at ACVIM

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...

May 07, 2015, 16:20 ET

Aratana Therapeutics Reports First Quarter 2015 Results

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

May 04, 2015, 08:55 ET

Traverse Biosciences Executes Agreement with Aratana Therapeutics to Advance Development of TRB-N0224 for the Treatment and Control of Periodontal Disease in Pets

 Traverse Biosciences announced today that it has executed a $250,000 cooperative research and development agreement (CRADA) with Aratana...

May 01, 2015, 08:33 ET

Aratana Therapeutics Inc. to Report first Quarter Results

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...

Apr 27, 2015, 09:02 ET

Aratana Therapeutics Comments on ADXS31-164 (AT-014) Study Data Presented During Poster Session at the American Association for Cancer Research (AACR) Annual Meeting 2015

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...

Apr 22, 2015, 07:30 ET

Aratana Therapeutics to Present at the Bank of America Merrill Lynch 2015 Health Care Conference

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...

Mar 19, 2015, 16:01 ET

Aratana Therapeutics to Present at the Jefferies 2015 Animal Health Summit

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...

Mar 12, 2015, 18:06 ET

Aratana Therapeutics Reports Fourth Quarter and Full Year 2014 Results

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

Mar 11, 2015, 07:00 ET

Aratana Therapeutics Inc. to Report Fourth Quarter and Year-End Financial Results

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...

Mar 04, 2015, 11:05 ET

Aratana Therapeutics to Present at the Barclays Global Healthcare Conference

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...

Feb 24, 2015, 16:01 ET

Aratana Therapeutics Regains Rights to AT-004

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...

Feb 10, 2015, 17:00 ET

Aratana Therapeutics Provides Product Updates

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...

Feb 06, 2015, 16:00 ET

Aratana Therapeutics to Present at the Leerink Global Healthcare Conference

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...

Jan 19, 2015, 09:00 ET

Aratana Therapeutics Awarded "Best Pipeline 2014" by Animal Pharm

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...

Jan 05, 2015, 16:30 ET

Aratana Therapeutics Granted Full License for AT-004 by USDA

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...

Dec 18, 2014, 16:52 ET

Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a biopharmaceutical company focused on the licensing, development and commercialization of...

Dec 16, 2014, 16:28 ET

Aratana Therapeutics Initiates Pivotal Study for AT-003

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...

Dec 05, 2014, 12:13 ET

Aratana Therapeutics to Present at the 2014 Animal & Dental Health Summit

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing or acquisition, development and commercialization of...